CONFIDENTIALITY OF AGREEMENTS. Except as otherwise required by law, the specific terms and conditions of this Agreement shall be Confidential Information but the existence and Field of this Agreement will not be Confidential Information and the Parties may state that COMPANY is licensed under the Patent Rights.
CONFIDENTIALITY OF AGREEMENTS. Except as otherwise required by law, the specific terms and conditions of this Agreement shall be Confidential Information but the existence of this Agreement will not be Confidential Information and the Parties may state that COMPANY is licensed under the Patent Rights. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. FINAL License Agreement page 13 of 22 MAYO [***]/ Evelo 8/07/2017
CONFIDENTIALITY OF AGREEMENTS. Except as otherwise required by law, the specific terms and conditions of this Agreement shall be the parties’ Confidential Information. However, the existence of this Agreement and its Field will not be Confidential Information, and the parties may state that Company is licensed by Mayo under the IP Rights.
CONFIDENTIALITY OF AGREEMENTS. The parties hereto will keep the terms of this Agreement and the other agreements contemplated by this Agreement confidential and will not, without the prior written consent of the other parties hereto, disclose such terms to any person or entity other than their accountants and attorneys who agree to be bound by this confidentiality provision, provided that this confidentiality obligation will terminate with respect to any information that becomes generally available to the public through no fault of the parties hereto or their accountants or attorneys.
CONFIDENTIALITY OF AGREEMENTS. Except as otherwise required by law, rules promulgated by the United States Securities and Exchange Commission (“SEC”) or the NASDAQ National Market, or the terms of this Agreement or as mutually agreed upon by the Parties hereto, each Party shall treat as confidential the specific terms and conditions of this Agreement and the University of Michigan Agreement (the existence, scope and general terms of each Agreement shall not be confidential). GSK acknowledges that ViroPharma shall file this Agreement with the SEC and, notwithstanding any other provision in this Agreement to the contrary, such filing with and disclosure by the SEC shall not constitute a breach of this Agreement; provided, however, that ViroPharma will request confidential treatment of the more sensitive terms hereof to the extent such confidential treatment is reasonably available. ViroPharma will provide GSK with an advance copy of the Agreement marked to show provisions for which ViroPharma intends to seek confidential treatment and will consider and take into account GSK’s reasonable comments thereon.
CONFIDENTIALITY OF AGREEMENTS. (a) Neither party shall make any press release about or other public statement or announcement concerning, or disclose to any third party the existence or dislcose any of the terms and conditions of, this Agreement, the Related Agreements or any commercial arrangement between the parties without the prior written consent of the other party.
(b) The foregoing notwithstanding, however, (i) a party may make any disclosure to its Affiliates and to its directors, officers, employees, attorneys and accountants, and to the underwriters engaged by the Company in connection with any offering of its securities, whose duties reasonably require familiarity with such matters, provided that such persons (including any such underwriters) are bound to maintain the confidentiality of such matters, and (ii) a party may make such disclosure as may be required by applicable law or regulation, in which case the disclosing party shall give the other party prompt advance notice of such disclosure so that the other party has the opportunity if it so desires to seek a protective order or other appropriate remedy; provided that, in connection with any offering of securities of the Company, the Company shall provide in advance to the Investor for review the form and content of any disclosure of any of such matters that may be required by law or regulation and, to the extent consistent with its disclosure obligations under applicable law, the Company shall include such modifications to such disclosure as may be reasonably requested by the Investor (except that the Company may file any of the Agreements as an exhibit to its registration statement if any of the Agreements would constitute a "material agreement" under applicable law or regulation and the Company shall use its best efforts to obtain confidential treatment of the portions of any such Agreements that meet the Securities and Exchange Commission qualifications for confidential treatment if so requested by Investor).
CONFIDENTIALITY OF AGREEMENTS. Except as otherwise required by law, the specific terms and conditions of this Agreement shall be Confidential Information but the Parties may state that COMPANY is licensed under the MAYO thin film electrode technology Know-How.
CONFIDENTIALITY OF AGREEMENTS. Except as otherwise required by law, by the terms of this Agreement, or mutually agreed upon by the Parties hereto, the specific terms and conditions of this Agreement shall be Confidential Information of Licensors.
CONFIDENTIALITY OF AGREEMENTS. Except as otherwise required by law, the specific terms and conditions of this Agreement shall be Confidential Information but the existence and Field of this Agreement will not be Confidential Information and the Parties may state that SORRENTO is licensed under the Licensed IP.
CONFIDENTIALITY OF AGREEMENTS. Except as expressly authorized in this Agreement or any Ancillary Agreement or as otherwise required by law or stock exchange requirement, each Member shall keep confidential and not disclose, and shall cause their respective Affiliates and directors, officers and employees of such Member and its Affiliates to (and shall instruct any of its other agents, advisors, consultants, other than counsel or auditors who are bound by an ethical obligation of confidentiality, and independent contractors to whom disclosure may be made in connection with the negotiation and performance of this Agreement or any Ancillary Agreement to) keep confidential and not disclose, and agrees that the Company shall keep confidential and not disclose any of the terms and conditions of this Agreement or any Ancillary Agreement to any third party without the unanimous approval of the Members, provided that a Member, the Company and their Affiliates may disclose the contents of any such agreement to (i) any potential Transferee Member or Additional Equity Member, any potential acquirer of assets from the Company, or any other party with whom the Company may enter into a business combination, and (ii) investment or commercial bankers, and other financial institutions or lenders, and their counsel (persons receiving information under items (i) and (ii) shall receive and treat such information as the confidential information of such Member, the Company and/or their Affiliates, as applicable) in connection with performance of customary due diligence by such parties.
